State of Alaska Department of Revenue Has $714,000 Position in Astrana Health, Inc. (NASDAQ:ASTH)

State of Alaska Department of Revenue reduced its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 2.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 23,033 shares of the company’s stock after selling 528 shares during the quarter. State of Alaska Department of Revenue’s holdings in Astrana Health were worth $714,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of ASTH. Truist Financial Corp acquired a new position in shares of Astrana Health during the 4th quarter worth about $315,000. Handelsbanken Fonder AB grew its position in shares of Astrana Health by 4.7% during the 4th quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company’s stock worth $281,000 after buying an additional 400 shares during the period. Illinois Municipal Retirement Fund grew its position in shares of Astrana Health by 16.8% during the 4th quarter. Illinois Municipal Retirement Fund now owns 24,987 shares of the company’s stock worth $788,000 after buying an additional 3,593 shares during the period. US Bancorp DE grew its position in shares of Astrana Health by 3,880.0% during the 4th quarter. US Bancorp DE now owns 4,776 shares of the company’s stock worth $151,000 after buying an additional 4,656 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Astrana Health by 5.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 471,329 shares of the company’s stock worth $14,861,000 after buying an additional 23,533 shares during the period. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Robert W. Baird decreased their target price on Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. Barclays began coverage on Astrana Health in a research report on Tuesday, April 1st. They set an “equal weight” rating and a $36.00 target price for the company. Bank of America cut their price objective on Astrana Health from $55.00 to $49.00 and set a “buy” rating on the stock in a report on Tuesday, March 4th. Finally, Truist Financial cut their price objective on Astrana Health from $50.00 to $46.00 and set a “buy” rating on the stock in a report on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $53.29.

Astrana Health Trading Up 0.0%

NASDAQ:ASTH opened at $24.73 on Friday. Astrana Health, Inc. has a fifty-two week low of $23.12 and a fifty-two week high of $63.20. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.70 and a quick ratio of 1.70. The stock has a market capitalization of $1.39 billion, a PE ratio of 34.35, a price-to-earnings-growth ratio of 1.33 and a beta of 0.85. The business’s 50-day simple moving average is $27.20 and its 200-day simple moving average is $31.18.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, May 8th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.09). The firm had revenue of $620.39 million during the quarter, compared to the consensus estimate of $628.11 million. Astrana Health had a net margin of 1.56% and a return on equity of 4.90%. The company’s revenue was up 53.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.31 EPS. Sell-side analysts expect that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.